MEDP logoMEDP
Medpace Holdings Inc

1,559
Loading...
Loading...
News
all
press releases
The Zacks Analyst Blog Highlights Hasbro, Robinhood Markets, Interactive Brokers, Celsius and Medpace
Hasbro, Robinhood, Interactive Brokers, Celsius, and Medpace are top non-tech Nasdaq stocks showing strong growth and robust earnings potential in 2025.
Zacks·15h ago
News Placeholder
More News
News Placeholder
Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study
PLSE wins FDA IDE approval for its NANOCLAMP AF study, advancing nsPFA tech as a novel option in atrial fibrillation surgery.
Zacks·1d ago
News Placeholder
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
Zacks·1d ago
News Placeholder
5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025
Non-tech Nasdaq standouts like HAS, HOOD, IBKR, CELH and MEDP are fueling 2025's index surge.
Zacks·1d ago
News Placeholder
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
WST rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
Zacks·1d ago
News Placeholder
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.
Zacks·2d ago
News Placeholder
Dentsply Sirona Retains Wellspect Following Strategic Review
XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.
Zacks·2d ago
News Placeholder
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.
Zacks·3d ago
News Placeholder
Lifeward Achieves European Approval for Latest ReWalk Exoskeleton
LFWD secures CE mark for its ReWalk 7 Personal Exoskeleton, unlocking new European sales potential with advanced features.
Zacks·3d ago
News Placeholder
Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Medpace (MEDP) settling at $492.09, representing a +1.05% change from its previous close.
Zacks·4d ago

Latest MEDP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.